Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de David T. Hung
Leeftijd : 62
Vermogen : 551 424 547 USD
Belangrijkste bedrijven : NovoCure Limited - Nuvation Bio Inc.
Overzicht 
Founder of 5 different companies, including: Medivation LLC (California), Nuvation Bio, Inc. and Medivation, Inc. David T. Hung is an entrepreneur and businessperson who has been the head of 10 different companies and presently occupies the position of President, Chief Executive Officer & Director at Repharmation, Inc. (which he founded) and President, CEO & Director at Nuvation Bio, Inc. (which he founded in 2018), President, Chief Executive Officer & Director at Nuvation Bio Operating Co., Inc. (which he founded in 2018) (a subsidiary of Nuvation Bio, Inc.).

He is also on the board of 5 other companies.

In his past career he was Chief Executive Officer & Director at Sio Gene Therapies, Inc. and Chief Executive Officer & Director at Axovant Sciences, Inc. (a subsidiary of Sio Gene Therapies, Inc.), President & Chief Executive Officer at Orion Acquisition Corp. II, President, Chief Executive Officer & Director at Pro-Duct Health, Inc., President, Chief Executive Officer & Director at Medivation, Inc. (he founded the company in 2003), President, Chief Executive Officer & Director at Medivation LLC (California) (he founded the company in 1995), President, Chief Executive Officer & Director at Medivation Neurology LLC, VP-Lead Discovery, Development & New Projects at Chiron Corp. and Consultant at Cytyc Health Corp.

He received an undergraduate degree from Harvard College and a doctorate from UCSF School of Medicine.


Posities en verantwoordelijkheden van David T. Hung 
NaamTitel Van
NovoCure Limited
(Medische apparatuur, benodigdheden & distributie)
Independent Director 2018
Nuvation Bio Inc.
(Biotechnologie & Medisch Onderzoek)
President, CEO & Director 2018
NKT Therapeutics, Inc. Director -
Establishment Labs SA Director 2016
Repharmation, Inc. President, Chief Executive Officer & Director -
Auransa Director -
Nuvation Bio Operating Co., Inc. President, Chief Executive Officer & Director 2018


Belangnemingen van David T. Hung 
NaamAandelen%Totale waarde
Nuvation Bio Inc. (NUVB)
(Biotechnologie & Medisch Onderzoek)
58 645 01226,9%541 293 461 USD
Nuvation Bio, Inc.1 000 0006,37%9 230 000 USD
NovoCure Limited (NVCR)
(Medische apparatuur, benodigdheden & distributie)
6 7140,0065%901 086 USD
Establishment Labs Holdings Inc. (ESTA)
(Medische apparatuur, benodigdheden & distributie)
00,0000%0 USD


David T. HungPersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
David T. Hung Verbindingen